Get started
Author

Luying Cui

ORCID: 0009-0002-3678-7979
Observed ORCID: 0009-0002-3678-7979
OpenAlex ID: A5113354595
Targeting Arachidonic Acid Metabolism Enhances Immunotherapy Efficacy in ARID1A-Deficient Colorectal Cancer
2024 · Luying Cui, Ruiqi Liu, et al. · Cancer Research · 36
USP15 Facilitates Colorectal Cancer Immune Evasion through SMYD3/CCL2-Dependent Myeloid-Derived Suppressor Cell Recruitment
2025 · Shuling Han, Luying Cui, et al. · Cancer Immunology Research · 16
Multiomics Reveals the Immunologic Features and the Immune Checkpoint Blockade Potential of Colorectal Medullary Carcinoma
2024 · Chao Liu, Haoyi Zou, et al. · Clinical Cancer Research · 8
CNOT7 facilitates radiation resistance in colorectal cancer through TRIM21/XRCC6-mediated non-homologous end joining repair
2025 · Yien Li, Luying Cui, et al. · Cell Death and Disease · 3
PDF
Dynamic Expression Quantitative Trait Locus Mendelian Randomization in Activated CD4‐Positive T Cells Nominates SMDT1 and CMTM7 as Candidate Genes in Pancreatic Cancer
2026 · Haitao Wang, Bingbing Wang, et al. · Molecular Carcinogenesis
Supplementary Figure 10 from USP15 Facilitates Colorectal Cancer Immune Evasion through SMYD3/CCL2-Dependent Myeloid-Derived Suppressor Cell Recruitment
2025 · Shuling Han, Luying Cui, et al.
Supplementary Figure 2 from USP15 Facilitates Colorectal Cancer Immune Evasion through SMYD3/CCL2-Dependent Myeloid-Derived Suppressor Cell Recruitment
2025 · Shuling Han, Luying Cui, et al.
Supplementary Figure 5 from USP15 Facilitates Colorectal Cancer Immune Evasion through SMYD3/CCL2-Dependent Myeloid-Derived Suppressor Cell Recruitment
2025 · Shuling Han, Luying Cui, et al.
Supplementary Figure 3 from USP15 Facilitates Colorectal Cancer Immune Evasion through SMYD3/CCL2-Dependent Myeloid-Derived Suppressor Cell Recruitment
2025 · Shuling Han, Luying Cui, et al.
Supplementary Figure 11 from USP15 Facilitates Colorectal Cancer Immune Evasion through SMYD3/CCL2-Dependent Myeloid-Derived Suppressor Cell Recruitment
2025 · Shuling Han, Luying Cui, et al.
Supplementary Figure 1 from USP15 Facilitates Colorectal Cancer Immune Evasion through SMYD3/CCL2-Dependent Myeloid-Derived Suppressor Cell Recruitment
2025 · Shuling Han, Luying Cui, et al.
Data from USP15 Facilitates Colorectal Cancer Immune Evasion through SMYD3/CCL2-Dependent Myeloid-Derived Suppressor Cell Recruitment
2025 · Shuling Han, Luying Cui, et al.
Supplementary Table 3 from USP15 Facilitates Colorectal Cancer Immune Evasion through SMYD3/CCL2-Dependent Myeloid-Derived Suppressor Cell Recruitment
2025 · Shuling Han, Luying Cui, et al.
Supplementary Figure 6 from USP15 Facilitates Colorectal Cancer Immune Evasion through SMYD3/CCL2-Dependent Myeloid-Derived Suppressor Cell Recruitment
2025 · Shuling Han, Luying Cui, et al.
Supplementary Figure 8 from USP15 Facilitates Colorectal Cancer Immune Evasion through SMYD3/CCL2-Dependent Myeloid-Derived Suppressor Cell Recruitment
2025 · Shuling Han, Luying Cui, et al.
Supplementary Figure 4 from USP15 Facilitates Colorectal Cancer Immune Evasion through SMYD3/CCL2-Dependent Myeloid-Derived Suppressor Cell Recruitment
2025 · Shuling Han, Luying Cui, et al.
Supplementary Figure 9 from USP15 Facilitates Colorectal Cancer Immune Evasion through SMYD3/CCL2-Dependent Myeloid-Derived Suppressor Cell Recruitment
2025 · Shuling Han, Luying Cui, et al.
Supplementary Table 1 from USP15 Facilitates Colorectal Cancer Immune Evasion through SMYD3/CCL2-Dependent Myeloid-Derived Suppressor Cell Recruitment
2025 · Shuling Han, Luying Cui, et al.
Supplementary Figure 7 from USP15 Facilitates Colorectal Cancer Immune Evasion through SMYD3/CCL2-Dependent Myeloid-Derived Suppressor Cell Recruitment
2025 · Shuling Han, Luying Cui, et al.
Supplementary Table 2 from USP15 Facilitates Colorectal Cancer Immune Evasion through SMYD3/CCL2-Dependent Myeloid-Derived Suppressor Cell Recruitment
2025 · Shuling Han, Luying Cui, et al.
Supplementary Table 2 from Targeting Arachidonic Acid Metabolism Enhances Immunotherapy Efficacy in ARID1A-Deficient Colorectal Cancer
2025 · Luying Cui, Ruiqi Liu, et al.
Materials and Methods from Targeting Arachidonic Acid Metabolism Enhances Immunotherapy Efficacy in ARID1A-Deficient Colorectal Cancer
2025 · Luying Cui, Ruiqi Liu, et al.
Figure S1-12 from Targeting Arachidonic Acid Metabolism Enhances Immunotherapy Efficacy in ARID1A-Deficient Colorectal Cancer
2025 · Luying Cui, Ruiqi Liu, et al.
Raw metabolomics data from Targeting Arachidonic Acid Metabolism Enhances Immunotherapy Efficacy in ARID1A-Deficient Colorectal Cancer
2025 · Luying Cui, Ruiqi Liu, et al.
Supplementary WB raw data from Targeting Arachidonic Acid Metabolism Enhances Immunotherapy Efficacy in ARID1A-Deficient Colorectal Cancer
2025 · Luying Cui, Ruiqi Liu, et al.
Works count: 73
Citation count: 63
H-index: 3
I10-index: 2
Year
Topic
Type